Psychedelic Therapy Training Program for Physicians & Prescribers

Embark on a transformative journey with our Psychedelic Therapy Training Program, designed specifically for physicians and prescribers.

This comprehensive course leverages the innovative potential of psychedelic medicine to foster deep connections with oneself, others, and the world.

Enroll Now - $1897

Depending on your location, options to spread your payments will be available on the checkout page.

Course curriculum

Led by ATMA, a pioneer in legal psychedelic-assisted therapy in Canada, the program offers 126 lessons and 14.5 hours of video content, equipping medical professionals with the knowledge and skills to integrate psychedelic therapies into their practice. Discover a new frontier in healing and personal growth.

    1. Welcome!

    2. Mark Haden

    3. Dr. Devon Christie

    4. Bruce Sanguin

    5. Saundra Jain

    6. Dr. Rakesh Jain

    7. Dr. Anthony Bossis

    8. Kim Haxton

    9. Dr. Ben Malcolm

    10. Alex Belser

    11. Dr. Pam Kryskow

    12. Zach Walsh

    13. Dr. Ravinder Bains

    14. Dr. Monika Hooper

    1. M1 Overview: Psychedelics are Medicine - Mark Haden

    2. M1 Overview: The Categories of Psychedelics - Mark Haden

    3. M1 Overview: Psychedelics - Nature vs Lab - Dr. Rakesh Jain

    4. M1 Overview: Are manmade compounds missing out on the full spectrum of what nature can provide? - Dr. Rakesh Jain

    5. M1 Overview: The Benefits of the Psychedelic Experience - Alex Belser

    6. M1 Overview: Psychedelics and the Prescriber - Monika Hooper

    7. M1 Overview: Psychedelics in the Context of Holistic Psychiatric Care - Monika Hooper

    8. M1 History: History Of Psychedelics - Mark Haden

    9. M1: History: Untold History Of Psychedelics - Mark Haden

    10. M1 Current Study and Research of Psychedelics: Section 56 Exemptions, SAP and Trials-Accessing Psychedelics - Mark Haden

    11. M1 Current Study and Research of Psychedelics: Microdosing Psychedelics - Zach Walsh

    12. M1 BONUS MATERIAL: Current Study and Research of Psychedelics: Microdosing Survey Outcomes - Zach Walsh

    13. M1 Current Study and Research of Psychedelics: Psychedelics and Wellness Study 2019 - Saundra Jain

About this course

  • Free
  • 27 lessons
  • 2.5 hours of video content

Instructor(s)

ATMA Training

ATMA is a Canadian company focused on delivering effective and innovative healing and transformative experiences that leverage the potential of psychedelic medicine to awaken the inner healer and allow a deeper connection with self, with others and with the beauty of our world.  ATMA was the first private company in Canada to conduct legal psychedelic-assisted therapy with psilocybin, one of the active hallucinogens found in ‘magic mushrooms’.